361 related articles for article (PubMed ID: 33604380)
1. CDCA3 Is a Novel Prognostic Biomarker Associated with Immune Infiltration in Hepatocellular Carcinoma.
Wang Z; Chen S; Wang G; Li S; Qin X
Biomed Res Int; 2021; 2021():6622437. PubMed ID: 33604380
[TBL] [Abstract][Full Text] [Related]
2. CCL14 is a prognostic biomarker and correlates with immune infiltrates in hepatocellular carcinoma.
Gu Y; Li X; Bi Y; Zheng Y; Wang J; Li X; Huang Z; Chen L; Huang Y; Huang Y
Aging (Albany NY); 2020 Jan; 12(1):784-807. PubMed ID: 31927532
[TBL] [Abstract][Full Text] [Related]
3. Identification of Rad51 as a prognostic biomarker correlated with immune infiltration in hepatocellular carcinoma.
Xu H; Xiong C; Chen Y; Zhang C; Bai D
Bioengineered; 2021 Dec; 12(1):2664-2675. PubMed ID: 34115569
[TBL] [Abstract][Full Text] [Related]
4. TANK-Binding Kinase 1 (TBK1) Serves as a Potential Target for Hepatocellular Carcinoma by Enhancing Tumor Immune Infiltration.
Jiang Y; Chen S; Li Q; Liang J; Lin W; Li J; Liu Z; Wen M; Cao M; Hong J
Front Immunol; 2021; 12():612139. PubMed ID: 33679751
[TBL] [Abstract][Full Text] [Related]
5. Expression, immune infiltration and clinical significance of SPAG5 in hepatocellular carcinoma: A gene expression-based study.
Chen W; Chen X; Li S; Ren B
J Gene Med; 2020 Apr; 22(4):e3155. PubMed ID: 31860771
[TBL] [Abstract][Full Text] [Related]
6. DCK is a promising prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma.
Song D; Wang Y; Zhu K; Tian L; Gao Q; Zhou J; Fan J; Wang X
World J Surg Oncol; 2020 Jul; 18(1):176. PubMed ID: 32690026
[TBL] [Abstract][Full Text] [Related]
7. MARCKS on Tumor-Associated Macrophages is Correlated with Immune Infiltrates and Poor Prognosis in Hepatocellular Carcinoma.
Ren X; Ju Y; Wang C; Wei R; Sun H; Zhang Q
Cancer Invest; 2021 Oct; 39(9):756-768. PubMed ID: 34279157
[TBL] [Abstract][Full Text] [Related]
8. Identification of Prognostic Genes in the Tumor Microenvironment of Hepatocellular Carcinoma.
Xiang S; Li J; Shen J; Zhao Y; Wu X; Li M; Yang X; Kaboli PJ; Du F; Zheng Y; Wen Q; Cho CH; Yi T; Xiao Z
Front Immunol; 2021; 12():653836. PubMed ID: 33897701
[No Abstract] [Full Text] [Related]
9. Transcriptional analysis of the expression, prognostic value and immune infiltration activities of the COMMD protein family in hepatocellular carcinoma.
Wang X; He S; Zheng X; Huang S; Chen H; Chen H; Luo W; Guo Z; He X; Zhao Q
BMC Cancer; 2021 Sep; 21(1):1001. PubMed ID: 34493238
[TBL] [Abstract][Full Text] [Related]
10. Correlation analysis of RDM1 gene with immune infiltration and clinical prognosis of hepatocellular carcinoma.
Qiu C; Li Z; Cao W; Cai X; Ye L; Zhang C; Ma Y; Wang X; Yang Y
Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 34435618
[TBL] [Abstract][Full Text] [Related]
11. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.
Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L
Front Immunol; 2019; 10():6. PubMed ID: 30761122
[No Abstract] [Full Text] [Related]
12. Cell division cycle associated 8: A novel diagnostic and prognostic biomarker for hepatocellular carcinoma.
Cui XH; Peng QJ; Li RZ; Lyu XJ; Zhu CF; Qin XH
J Cell Mol Med; 2021 Dec; 25(24):11097-11112. PubMed ID: 34741389
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of orosomucoid 2 acts as a prognostic factor associated with cancer-promoting pathways in liver cancer.
Zhu HZ; Zhou WJ; Wan YF; Ge K; Lu J; Jia CK
World J Gastroenterol; 2020 Feb; 26(8):804-817. PubMed ID: 32148378
[TBL] [Abstract][Full Text] [Related]
14. Identification of CDC20 as an immune infiltration-correlated prognostic biomarker in hepatocellular carcinoma.
Xiong C; Wang Z; Wang G; Zhang C; Jin S; Jiang G; Bai D
Invest New Drugs; 2021 Oct; 39(5):1439-1453. PubMed ID: 33942202
[TBL] [Abstract][Full Text] [Related]
15. High mRNA Expression of
Cui Z; Xiao L; Chen F; Wang J; Lin H; Li D; Wu Z
Dis Markers; 2021; 2021():9971799. PubMed ID: 34457090
[TBL] [Abstract][Full Text] [Related]
16. Six Cell Cycle-related Genes Serve as Potential Prognostic Biomarkers and Correlated with Immune Infiltrates in Hepatocellular Carcinoma.
Shi Y; Sang X; Deng J; Wang Y; Chen X; Lin S; Wu F; Xu A
J Cancer; 2023; 14(1):9-23. PubMed ID: 36605491
[No Abstract] [Full Text] [Related]
17. PPM1D is a potential prognostic biomarker and correlates with immune cell infiltration in hepatocellular carcinoma.
Yu Z; Song Y; Cai M; Jiang B; Zhang Z; Wang L; Jiang Y; Zou L; Liu X; Yu N; Mao X; Peng C; Liu S
Aging (Albany NY); 2021 Sep; 13(17):21294-21308. PubMed ID: 34470916
[TBL] [Abstract][Full Text] [Related]
18. Highly expressed centromere protein L indicates adverse survival and associates with immune infiltration in hepatocellular carcinoma.
Zeng Z; Jiang X; Pan Z; Zhou R; Lin Z; Tang Y; Cui Y; Zhang E; Cao Z
Aging (Albany NY); 2021 Oct; 13(19):22802-22829. PubMed ID: 34607313
[TBL] [Abstract][Full Text] [Related]
19. Hydroxysteroid 17-Beta Dehydrogenase 6 Is a Prognostic Biomarker and Correlates with Immune Infiltrates in Hepatocellular Carcinoma.
Wu M; Jiang L
Dig Dis Sci; 2022 Jan; 67(1):146-158. PubMed ID: 33495920
[TBL] [Abstract][Full Text] [Related]
20. EOGT Correlated With Immune Infiltration: A Candidate Prognostic Biomarker for Hepatocellular Carcinoma.
Shu Y; He L; Gao M; Xiao F; Yang J; Wang S; Wei H; Zhang F; Wei H
Front Immunol; 2021; 12():780509. PubMed ID: 35069551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]